ATE161737T1 - Biokeramisches system zur abgabe von bioaktiven stoffen - Google Patents

Biokeramisches system zur abgabe von bioaktiven stoffen

Info

Publication number
ATE161737T1
ATE161737T1 AT91910901T AT91910901T ATE161737T1 AT E161737 T1 ATE161737 T1 AT E161737T1 AT 91910901 T AT91910901 T AT 91910901T AT 91910901 T AT91910901 T AT 91910901T AT E161737 T1 ATE161737 T1 AT E161737T1
Authority
AT
Austria
Prior art keywords
bioactive
release
bioceramic system
bioactive substances
compound
Prior art date
Application number
AT91910901T
Other languages
English (en)
Inventor
Antti Uuno Uolevi Yli-Urpo
Harry Goesta Jalonen
Kauko Oiva Antero Kurkela
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE161737T1 publication Critical patent/ATE161737T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/08—Stiffening bandages containing inorganic materials, e.g. plaster of Paris
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
  • Glass Compositions (AREA)
AT91910901T 1990-06-25 1991-06-24 Biokeramisches system zur abgabe von bioaktiven stoffen ATE161737T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9014052A GB2245559A (en) 1990-06-25 1990-06-25 Bioceramic system for delivery of a bioactive compound.

Publications (1)

Publication Number Publication Date
ATE161737T1 true ATE161737T1 (de) 1998-01-15

Family

ID=10678130

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910901T ATE161737T1 (de) 1990-06-25 1991-06-24 Biokeramisches system zur abgabe von bioaktiven stoffen

Country Status (17)

Country Link
US (1) US5762950A (de)
EP (1) EP0536179B1 (de)
JP (1) JPH05507867A (de)
KR (1) KR930700166A (de)
AT (1) ATE161737T1 (de)
AU (1) AU652945B2 (de)
DE (1) DE69128621T2 (de)
FI (1) FI925845L (de)
GB (1) GB2245559A (de)
HU (1) HUT64214A (de)
IE (1) IE912191A1 (de)
NZ (1) NZ238675A (de)
PL (2) PL166849B1 (de)
PT (1) PT98080B (de)
SK (1) SK377792A3 (de)
WO (1) WO1992000109A1 (de)
ZA (1) ZA914839B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
US5851993A (en) * 1994-06-13 1998-12-22 Biotie Therapies Ltd. Suppression of tumor cell growth by syndecan-1 ectodomain
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6132463A (en) * 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
AU771272B2 (en) * 1995-06-13 2004-03-18 Zahra Mansouri Methods of delivering materials into the skin and compositions used therein
US6579516B1 (en) * 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
JP3457680B2 (ja) * 1996-05-01 2003-10-20 ユーエスバイオマテリアルズ コーポレイション 生物活性セラミックス及び生物活性セラミックスの製造方法
ES2299183T3 (es) 1996-10-16 2008-05-16 Etex Corporation Composiciones bioceramicas.
FI103715B1 (fi) * 1997-04-21 1999-08-31 Heimo Ylaenen Uusi komposiitti ja sen käyttö
TW496741B (en) * 1998-03-12 2002-08-01 Dept Of Health R O C Radioactive particles and method for producing the same
US7628997B1 (en) * 1999-07-09 2009-12-08 Schott Ag Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
US7323160B2 (en) * 1999-08-14 2008-01-29 Teldent Ltd. Method of treating a patient's teeth using fluoride releasing glass composition
GB9919283D0 (en) * 1999-08-14 1999-10-20 Algar Brian A glass composition
WO2001072145A1 (en) * 2000-03-24 2001-10-04 Ustherapeutics, Llc Nutritional supplements formulated from bioactive materials
TWI246921B (en) * 2000-04-11 2006-01-11 Sankyo Co Stabilized pharmaceutical composition with calcium blocker
US6514193B2 (en) * 2000-11-16 2003-02-04 Microspherix Llc Method of administering a therapeutically active substance
WO2004026111A2 (en) 2000-11-16 2004-04-01 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US8168208B1 (en) * 2002-06-03 2012-05-01 Ahmed El-Ghannam Silica-calcium phosphate bioactive composite for improved synthetic graft resorbability and tissue regeneration
KR20040010200A (ko) * 2002-07-15 2004-01-31 펜탁스 가부시키가이샤 ＣａＯ-ＳｉＯ2계 생체활성 유리 및 그것을 사용하는인산칼슘 유리 소결체
DE10307646B3 (de) 2003-02-21 2004-10-21 Ivoclar Vivadent Ag Bioaktive Rhenanit-Glaskeramik, Verfahren zu ihrer Herstellung und ihre Verwendung
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
WO2005016318A1 (en) * 2003-08-08 2005-02-24 Biovail Laboratories Inc. Modified-release tablet of bupropion hydrochloride
EP1819313B1 (de) * 2004-11-16 2010-12-29 3M Innovative Properties Company Dentalfüllstoffe und zusammensetzungen mit phosphatsalzen
CA2587556A1 (en) 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
KR101240883B1 (ko) 2004-11-16 2013-03-07 쓰리엠 이노베이티브 프로퍼티즈 컴파니 카제이네이트를 포함하는 치과용 충전제, 방법, 조성물
US8957126B2 (en) 2004-11-16 2015-02-17 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
EP1909859B1 (de) 2005-07-21 2017-09-06 aap Biomaterials GmbH Verfahren zur herstellung von hydroxylapatit-teilchen, insbesondere von subnanodispersen hydroxylapatit-teilchen in einer matrix
US7736293B2 (en) * 2005-07-22 2010-06-15 Biocompatibles Uk Limited Implants for use in brachytherapy and other radiation therapy that resist migration and rotation
US8187159B2 (en) 2005-07-22 2012-05-29 Biocompatibles, UK Therapeutic member including a rail used in brachytherapy and other radiation therapy
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US20080241256A1 (en) * 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles
EP2229130A2 (de) * 2007-12-13 2010-09-22 3M Innovative Properties Company Remineralisierende zusammensetzungen und verfahren
WO2010068359A1 (en) * 2008-12-11 2010-06-17 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
CN103006700B (zh) * 2011-09-20 2016-08-17 常州倍尔生生物科技有限公司 pH缓冲生物活性玻璃及其制备方法和用途
US11896612B2 (en) * 2019-03-29 2024-02-13 Board Of Trustees Of Michigan State University Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles
CA3246974A1 (en) * 2022-04-01 2023-10-05 EMPLICURE AB (publ) ALKALINE INTRAORAL PRODUCTS

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135935A (en) * 1973-09-17 1979-01-23 Ernst Leitz Wetzlar Gmbh Sintered composite material, a process of making same, and a method of using same
DE2501683C3 (de) * 1975-01-17 1979-11-29 Ernst Leitz Wetzlar Gmbh, 6300 Wetzlar Polymeres Verbundmaterial für prothetische Zwecke und Verfahren zu seiner Herstellung
CH595293A5 (de) * 1975-02-20 1978-02-15 Battelle Memorial Institute
JPS5839533B2 (ja) * 1975-12-30 1983-08-30 住友化学工業株式会社 インプラントノセイゾウホウホウ
US4334029A (en) * 1980-01-09 1982-06-08 Mizusawa Kazahu Kogyo Kabushiki Kaisha Unfired refractory composition
JPS59101145A (ja) * 1982-11-30 1984-06-11 日本特殊陶業株式会社 薬液含浸多孔質セラミツクス
GB8331661D0 (en) * 1983-11-26 1984-01-04 Standard Telephones Cables Ltd Water soluble glass composition
US4655777A (en) * 1983-12-19 1987-04-07 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
JPS60186455A (ja) * 1984-03-06 1985-09-21 株式会社ニコン アパタイトコンポジツトセラミクス
CH665357A5 (de) * 1985-07-05 1988-05-13 Werther Lusuardi Knochenzement.
JPS6272540A (ja) * 1985-09-26 1987-04-03 Nippon Electric Glass Co Ltd 無アルカリ生体用結晶化ガラスとその製造方法
US4780450A (en) * 1985-12-20 1988-10-25 The University Of Maryland At Baltimore Physically stable composition and method of use thereof for osseous repair
EP0261593B1 (de) * 1986-09-24 1992-08-26 Lion Corporation Verfahren zur Herstellung eines Gelvorläufers eines bioaktiven Glases oder einer bioaktiven Glaskeramik
JPS6456056A (en) * 1987-08-26 1989-03-02 Dental Chem Co Ltd Hydroxyapatite bone filling material
JPH01172240A (ja) * 1987-12-26 1989-07-07 Central Glass Co Ltd 斑状模様入ガラス質焼成体およびその製法
JPH01265969A (ja) * 1988-04-19 1989-10-24 Asahi Glass Co Ltd 生体用材料及びその製造方法
JPH01275765A (ja) * 1988-04-28 1989-11-06 Seiko Epson Corp インプラント材の製造方法
JPH0629126B2 (ja) * 1989-03-29 1994-04-20 京都大学長 生体活性水酸アパタイト膜のコーティング法
US5356436A (en) * 1989-06-06 1994-10-18 Tdk Corporation Materials for living hard tissue replacements
US5232878A (en) * 1989-06-30 1993-08-03 Hoya Corporation Process for producing inorganic biomaterial
FR2651439B1 (fr) * 1989-09-06 1994-09-23 Fbfc International Sa Nv Materiau bioreactif pour prothese ou implants composites.
DD291982A5 (de) * 1990-02-12 1991-07-18 ���������`��������`����@����k�� Apatitglaskeramik, vorzugsweise fuer dentale glasionomerzemente
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
US5074916A (en) * 1990-05-18 1991-12-24 Geltech, Inc. Alkali-free bioactive sol-gel compositions
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5262166A (en) * 1991-04-17 1993-11-16 Lty Medical Inc Resorbable bioactive phosphate containing cements

Also Published As

Publication number Publication date
PL166919B1 (pl) 1995-07-31
PT98080B (pt) 1998-11-30
US5762950A (en) 1998-06-09
FI925845A0 (fi) 1992-12-23
FI925845A7 (fi) 1992-12-23
GB2245559A (en) 1992-01-08
EP0536179B1 (de) 1998-01-07
AU652945B2 (en) 1994-09-15
GB9014052D0 (en) 1990-08-15
DE69128621T2 (de) 1998-05-07
EP0536179A1 (de) 1993-04-14
WO1992000109A1 (en) 1992-01-09
SK377792A3 (en) 1995-01-12
PL166849B1 (pl) 1995-06-30
ZA914839B (en) 1992-04-29
JPH05507867A (ja) 1993-11-11
DE69128621D1 (de) 1998-02-12
NZ238675A (en) 1993-04-28
IE912191A1 (en) 1992-01-01
FI925845L (fi) 1992-12-23
HUT64214A (en) 1993-12-28
AU8082391A (en) 1992-01-23
PT98080A (pt) 1992-04-30
KR930700166A (ko) 1993-03-13

Similar Documents

Publication Publication Date Title
ATE161737T1 (de) Biokeramisches system zur abgabe von bioaktiven stoffen
DE3484933D1 (de) Implantat zur befestigung von zahnprothesen.
DE3880724D1 (de) Zusammensetzung mit langzeit-freigabe zur mikrobenbekaempfung und verfahren zur mikrobenbekaempfung mit genannter zusammensetzung.
DE3868910D1 (de) Implantat zur befestigung von zahnprothesen.
DE3877174D1 (de) Bezugssystem zur implantation von kondylaeren knie-totalprothesen.
DE69332210D1 (de) Biologisch abbaubares, schmelzgesponnenes abgabesystem zur kontrollierten freisetzung
EP0386757A3 (en) Biodegradable poly (phosphate esters)
DK0679097T3 (da) TGF-Beta-præparat til fremkaldelse af knoglevækst
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE3876724D1 (de) Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung.
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
DK121690A (da) Implantat til afgivelse af neurotransmitter
ATE106221T1 (de) Zahnimplantat zur befestigung von zahnersatz- suprakonstruktionen.
CA2251281A1 (en) Drug composition with controlled drug release rate
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
DE3764104D1 (de) Zusammensetzung zur regulierung des pflanzenwachstums.
IT9048524A0 (it) Composizione adesiva stabilizzante per protesi dentarie.
DE59103046D1 (de) Verfahren zur Herstellung von Alkylglycosiden und Alkylpolyglycosiden.
DE69535263D1 (de) Angiotensin ii zur verbesserung der befruchtung
DE69016606D1 (de) Zusammensetzungen zur kontrollierten Haftverminderung und ihre Verwendung.
DE69013077D1 (de) Zusammensetzung zur Regulation des Pflanzenwachstums.
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
DE69022711D1 (de) Einrichtung zur Regelung der Lichtmenge.
FI940917A7 (fi) Menetelmä ja koostumus mikro-organismien kasvun kontrolloimiseksi
DE3885752D1 (de) Methode und verbindungen zur herstellung von acsf und acsf-antagonisten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee